Can Neogen Corporation (NEOG) Become One of the Market’s Best Small-Cap Turnarounds?
Is Weaker Sales And Returns Reshaping The Investment Case For Neogen’s (NEOG) Valuation Assumptions?
3 Reasons NEOG is Risky and 1 Stock to Buy Instead
Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call
1 Unprofitable Stock on Our Watchlist and 2 Facing Challenges
Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance
NEOG Q1 Deep Dive: Margin Expansion, Supplier Challenges, and Transformation Initiatives
Neogen Corp (NEOG) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges
Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren’t Helping.
Neogen Corporation Q3 2026 Earnings Call Summary
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Neogen (NEOG) Q3 2025 Earnings Call Transcript
Neogen Q3 Earnings Call Highlights
NEOGEN CORP (NASDAQ:NEOG) Posts Q3 Beat but Cuts Outlook as Animal Safety Segment Slumps
Neogen Corporation (NEOG) Q3 2026 Earnings Call Transcript
Neogen shares are trading lower. The company reported Q3 financial results.
Neogen Corporation 2026 Q3 - Results - Earnings Call Presentation
Neogen Raises FY2026 Sales Guidance from $845.000M-$855.000M to $857.000M-$860.000M vs $850.576M Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.